Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Oppenheimer medical tech analyst to hold an analyst/industry conference call » 09:25
03/05/21
03/05
09:25
03/05/21
09:25
JNJ

Johnson & Johnson

$153.00 /

-3.11 (-1.99%)

, MDT

Medtronic

$115.10 /

-2.82 (-2.39%)

, ISRG

Intuitive Surgical

$709.48 /

-18.36 (-2.52%)

, TRXC

TransEnterix

$0.00 /

+ (+0.00%)

Medical Technology…

Medical Technology Analysts discuss the Evolving Regulatory Landscape for Robotic Surgery Devices on an Analyst/Industry Conference Call to be held on March 5 at 10 am.

ShowHide Related Items >><<
TRXC TransEnterix
$0.00 /

+ (+0.00%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$115.10 /

-2.82 (-2.39%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

01/22/21 JPMorgan
Intuitive Surgical price target raised to $840 from $825 at JPMorgan
01/22/21 Raymond James
Intuitive Surgical price target raised to $865 from $800 at Raymond James
01/22/21 Wells Fargo
Intuitive Surgical price target raised to $879 from $841 at Wells Fargo
01/22/21 Oppenheimer
Intuitive Surgical price target raised to $410 from $365 at Oppenheimer
TRXC TransEnterix
$0.00 /

+ (+0.00%)

01/20/21 Ladenburg
TransEnterix downgraded to Neutral on valuation at Ladenburg
01/20/21 Ladenburg
TransEnterix downgraded to Neutral from Buy at Ladenburg
TRXC TransEnterix
$0.00 /

+ (+0.00%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

TRXC TransEnterix
$0.00 /

+ (+0.00%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

TRXC TransEnterix
$0.00 /

+ (+0.00%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

Conference/Events
Oppenheimer medical tech analyst to hold an analyst/industry conference call » 04:55
03/05/21
03/05
04:55
03/05/21
04:55
JNJ

Johnson & Johnson

$153.00 /

-3.11 (-1.99%)

, MDT

Medtronic

$115.10 /

-2.82 (-2.39%)

, ISRG

Intuitive Surgical

$709.48 /

-18.36 (-2.52%)

, TRXC

TransEnterix

/

+

Medical Technology…

Medical Technology Analysts discuss the Evolving Regulatory Landscape for Robotic Surgery Devices on an Analyst/Industry Conference Call to be held on March 5 at 10 am.

ShowHide Related Items >><<
TRXC TransEnterix
/

+

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$115.10 /

-2.82 (-2.39%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

01/22/21 JPMorgan
Intuitive Surgical price target raised to $840 from $825 at JPMorgan
01/22/21 Raymond James
Intuitive Surgical price target raised to $865 from $800 at Raymond James
01/22/21 Wells Fargo
Intuitive Surgical price target raised to $879 from $841 at Wells Fargo
01/22/21 Oppenheimer
Intuitive Surgical price target raised to $410 from $365 at Oppenheimer
TRXC TransEnterix
/

+

01/20/21 Ladenburg
TransEnterix downgraded to Neutral on valuation at Ladenburg
01/20/21 Ladenburg
TransEnterix downgraded to Neutral from Buy at Ladenburg
TRXC TransEnterix
/

+

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

TRXC TransEnterix
/

+

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

TRXC TransEnterix
/

+

MDT Medtronic
$115.10 /

-2.82 (-2.39%)

JNJ Johnson & Johnson
$153.00 /

-3.11 (-1.99%)

ISRG Intuitive Surgical
$709.48 /

-18.36 (-2.52%)

Thursday
Hot Stocks
Medtronic announces first procedures in trial of PulseSelect System » 09:06
03/04/21
03/04
09:06
03/04/21
09:06
MDT

Medtronic

$117.91 /

+0.06 (+0.05%)

Medtronic announced the…

Medtronic announced the first procedures in the investigational device exemption pivotal trial to evaluate the PulseSelect Pulsed Field Ablation System, a novel technology that uses pulsed electric fields to treat atrial fibrillation. The first procedure in the PULSED AF pivotal trial was performed this week at Southcoast Health; the second procedure was also performed at Southcoast Health. Developed exclusively at Medtronic, the PulseSelect System delivers pulsed electric fields through an ablation catheter designed specifically to interrupt irregular electrical pathways in the heart that trigger atrial fibrillation. The PULSED AF trial is a clinical trial that will enroll up to 500 patients who will be treated with the PulseSelect System designed to evaluate the safety and efficacy of the PulseSelect System for the treatment of AF in adult patients with a history of drug refractory, recurrent and symptomatic paroxysmal or persistent AF.

ShowHide Related Items >><<
MDT Medtronic
$117.91 /

+0.06 (+0.05%)

MDT Medtronic
$117.91 /

+0.06 (+0.05%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MDT Medtronic
$117.91 /

+0.06 (+0.05%)

MDT Medtronic
$117.91 /

+0.06 (+0.05%)

MDT Medtronic
$117.91 /

+0.06 (+0.05%)

MDT Medtronic
$117.91 /

+0.06 (+0.05%)

Tuesday
Hot Stocks
Medtronic says new analysis of REVERSE trial shows CRT benefit for more patients » 10:32
03/02/21
03/02
10:32
03/02/21
10:32
MDT

Medtronic

$117.44 /

-0.39 (-0.33%)

Medtronic announced new…

Medtronic announced new results from the REVERSE trial, evaluating outcomes of cardiac resynchronization therapy, or CRT, for patients with mild heart failure, or HF. This new analysis of the REVERSE clinical trial shows that patients whose heart failure stabilizes with CRT live longer, similar to patients whose condition improves with CRT, said the company, which notes that the manuscript was recently published in the "Journal of American College of Cardiology: Clinical Electrophysiology." Rob Kowal, M.D., Ph.D., chief medical officer of Cardiac Rhythm Management, which is reported as part of the Cardiac and Vascular Group at Medtronic, said: "REVERSE reinforces the strong clinical evidence supporting CRT, and the value of CRT as an option to slow the progression of this debilitating disease. Time and again, the landmark CRT trials have demonstrated a range of patient stabilization or improvement with the application of cardiac resynchronization therapy."

ShowHide Related Items >><<
MDT Medtronic
$117.44 /

-0.39 (-0.33%)

MDT Medtronic
$117.44 /

-0.39 (-0.33%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MDT Medtronic
$117.44 /

-0.39 (-0.33%)

MDT Medtronic
$117.44 /

-0.39 (-0.33%)

MDT Medtronic
$117.44 /

-0.39 (-0.33%)

MDT Medtronic
$117.44 /

-0.39 (-0.33%)

Over a week ago
Hot Stocks
Medtronic recalls HVAD Pump Implant Kit over delayed, failed restart » 10:46
03/01/21
03/01
10:46
03/01/21
10:46
MDT

Medtronic

$118.54 /

+1.52 (+1.30%)

Medtronic is recalling…

Medtronic is recalling the HVAD Pump Implant Kit because the device may fail to initially start, restart, or have a delay in restarting after the pump was stopped, the FDA announced. These delays or failures to start or restart have occurred during preimplant testing, during the implant, or in a variety of post-implant situations, it added. If the device has delays or fails to start or restart, this could cause serious patient harm including a heart attack, worsening heart failure, the need for additional procedures and hospitalizations, or death, the agency said. There have been 29 complaints about this device issue, which include 19 serious injuries and eight cases of patients who had a life-threatening event but recovered without long term effects. The FDA has identified this as a Class I recall, the most serious type of recall. Reference Link

ShowHide Related Items >><<
MDT Medtronic
$118.54 /

+1.52 (+1.30%)

MDT Medtronic
$118.54 /

+1.52 (+1.30%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MDT Medtronic
$118.54 /

+1.52 (+1.30%)

MDT Medtronic
$118.54 /

+1.52 (+1.30%)

MDT Medtronic
$118.54 /

+1.52 (+1.30%)

MDT Medtronic
$118.54 /

+1.52 (+1.30%)

Recommendations
Nevro price target raised to $217 from $203 at Canaccord » 08:32
02/25/21
02/25
08:32
02/25/21
08:32
NVRO

Nevro

$171.76 /

+4.915 (+2.95%)

Canaccord analyst William…

Canaccord analyst William Plovanic raised the firm's price target on Nevro to $217 from $203 and keeps a Buy rating on the shares. The analyst is more encouraged about the company's prospects following its Q4 results. He sees several upcoming catalysts and the COVID headwinds abating while guidance appears conservative.

ShowHide Related Items >><<
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

02/02/21
Fly Intel: Top five analyst initiations
02/02/21 Piper Sandler
Nevro initiated with an Overweight at Piper Sandler
01/19/21 SVB Leerink
Nevro price target raised to $210 from $190 at SVB Leerink
01/19/21 Canaccord
Nevro price target raised to $203 from $167 at Canaccord
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

  • 02
    Apr
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
BIO

Bio-Rad

$594.44 /

+0.09 (+0.02%)

, DGX

Quest Diagnostics

$115.77 /

-1.73 (-1.47%)

, DXCM

DexCom

$405.52 /

-1.49 (-0.37%)

, EXAS

Exact Sciences

$135.04 /

-3.84 (-2.76%)

, HOLX

Hologic

$75.15 /

-0.4 (-0.53%)

, JNJ

Johnson & Johnson

$162.61 /

+2.105 (+1.31%)

, MDT

Medtronic

$118.73 /

+0.71 (+0.60%)

, MTD

Mettler-Toledo

$1,126.92 /

+15.75 (+1.42%)

, PEN

Penumbra

$288.57 /

+8.5 (+3.03%)

, PODD

Insulet

$262.39 /

+1.9 (+0.73%)

, SHC

Sotera Health

$26.72 /

+0.28 (+1.06%)

, SLQT

SelectQuote

$30.76 /

+0.795 (+2.65%)

, TECH

Bio-Techne

$374.73 /

-2.58 (-0.68%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$163.78 /

+1.96 (+1.21%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$405.52 /

-1.49 (-0.37%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.15 /

-0.4 (-0.53%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.73 /

+0.71 (+0.60%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

02/24/21 Canaccord
Penumbra price target raised to $310 from $204 at Canaccord
02/24/21 Wells Fargo
Penumbra price target raised to $310 from $260 at Wells Fargo
02/24/21 Citi
Penumbra price target raised to $325 from $255 at Citi
12/16/20
Fly Intel: Top five analyst downgrades
PODD Insulet
$262.39 /

+1.9 (+0.73%)

02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

On The Fly
Fly Intel: After-Hours Movers » 18:59
02/24/21
02/24
18:59
02/24/21
18:59
CCRN

Cross Country Healthcare

$10.05 /

+0.51 (+5.35%)

, TRUE

TrueCar

$5.07 /

+0.07 (+1.40%)

, RCII

Rent-A-Center

$54.52 /

+0.27 (+0.50%)

, RVLV

Revolve Group

$36.73 /

-0.36 (-0.97%)

, OPRX

OptimizeRx

$57.73 /

+2.23 (+4.02%)

, CPE

Callon Petroleum

$26.18 /

+1.71 (+6.99%)

, MAXR

Maxar Technologies

$45.52 /

-0.09 (-0.20%)

, CDNA

CareDx

$79.23 /

+2.13 (+2.76%)

, PSTG

Pure Storage

$25.78 /

+0.21 (+0.82%)

, NTNX

Nutanix

$32.81 /

+0.77 (+2.40%)

, LB

L Brands

$51.65 /

+0.525 (+1.03%)

, WOW

WideOpenWest

$13.03 /

+0.01 (+0.08%)

, MRNA

Moderna

$144.71 /

-5.315 (-3.54%)

, PING

Ping Identity

$32.52 /

+1.17 (+3.73%)

, WHD

Cactus

$33.92 /

+3.335 (+10.90%)

, PGNY

Progyny

$53.33 /

+2.09 (+4.08%)

, NTAP

NetApp

$71.48 /

+2.16 (+3.12%)

, KRA

Kraton

$44.65 /

+1.44 (+3.33%)

, ZVO

Zovio

$6.14 /

+0.68 (+12.45%)

, RDFN

Redfin

$91.61 /

+0.95 (+1.05%)

, GPRE

Green Plains

$26.02 /

+0.83 (+3.29%)

, TDOC

Teladoc

$253.50 /

-2.26 (-0.88%)

, AMED

Amedisys

$281.78 /

+1.51 (+0.54%)

, GBT

Global Blood Therapeutics

$49.20 /

+1.19 (+2.48%)

, GH

Guardant Health

$162.41 /

+2.14 (+1.34%)

, ACA

Arcosa

$68.21 /

+2.98 (+4.57%)

, IIPR

Innovative Industrial Properties

$220.34 /

+11.345 (+5.43%)

, NVRO

Nevro

$171.76 /

+4.915 (+2.95%)

, ESTC

Elastic

$157.48 /

+4.36 (+2.85%)

, PNTG

The Pennant Group

$57.96 /

+1.69 (+3.00%)

, SPTN

SpartanNash

$18.10 /

+0.055 (+0.30%)

, NVDA

Nvidia

$580.21 /

+14.61 (+2.58%)

, FTI

TechnipFMC

$7.60 /

+0.46 (+6.44%)

, HCC

Warrior Met Coal

$25.60 /

+0.175 (+0.69%)

Check out this evening's…

ShowHide Related Items >><<
ZVO Zovio
$6.14 /

+0.68 (+12.45%)

WHD Cactus
$33.92 /

+3.335 (+10.90%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

SPTN SpartanNash
$18.10 /

+0.055 (+0.30%)

RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RCII Rent-A-Center
$54.52 /

+0.27 (+0.50%)

PSTG Pure Storage
$25.78 /

+0.21 (+0.82%)

PNTG The Pennant Group
$57.96 /

+1.69 (+3.00%)

PING Ping Identity
$32.52 /

+1.17 (+3.73%)

PGNY Progyny
$53.33 /

+2.09 (+4.08%)

OPRX OptimizeRx
$57.73 /

+2.23 (+4.02%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NTNX Nutanix
$32.81 /

+0.77 (+2.40%)

NTAP NetApp
$71.48 /

+2.16 (+3.12%)

MRNA Moderna
$144.71 /

-5.315 (-3.54%)

MAXR Maxar Technologies
$45.52 /

-0.09 (-0.20%)

LB L Brands
$51.65 /

+0.525 (+1.03%)

KRA Kraton
$44.65 /

+1.44 (+3.33%)

IIPR Innovative Industrial Properties
$220.34 /

+11.345 (+5.43%)

HCC Warrior Met Coal
$25.60 /

+0.175 (+0.69%)

GPRE Green Plains
$26.02 /

+0.83 (+3.29%)

GH Guardant Health
$162.41 /

+2.14 (+1.34%)

GBT Global Blood Therapeutics
$49.20 /

+1.19 (+2.48%)

FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

CPE Callon Petroleum
$26.18 /

+1.71 (+6.99%)

CDNA CareDx
$79.23 /

+2.13 (+2.76%)

AMED Amedisys
$281.78 /

+1.51 (+0.54%)

ACA Arcosa
$68.21 /

+2.98 (+4.57%)

CCRN Cross Country Healthcare
$10.05 /

+0.51 (+5.35%)

11/25/20 Barrington
Cross Country Healthcare target raised to $12 at Barrington after Q3 results
11/23/20 BMO Capital
BMO upgrades Cross Country Healthcare to Outperform on success of turnaround
11/23/20 BMO Capital
Cross Country Healthcare upgraded to Outperform at BMO Capital
11/05/20 Benchmark
Cross Country Healthcare upgraded to Buy on demand tailwinds at Benchmark
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

01/25/21 Goldman Sachs
TrueCar reinstated with a Neutral at Goldman Sachs
11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
11/11/20 Truist
TrueCar price target lowered to $4.50 from $6 at Truist
11/09/20
Fly Intel: Top five analyst upgrades
RCII Rent-A-Center
$54.52 /

+0.27 (+0.50%)

02/24/21 Stephens
Aaron's peers also potentially received California inquiry, says Stephens
02/01/21 KeyBanc
Rent-A-Center upgraded to Overweight from Sector Weight at KeyBanc
02/01/21 KeyBanc
Rent-A-Center upgraded to Overweight from Sector Weight at KeyBanc
01/04/21 Loop Capital
Rent-A-Center selected as one of Loop Capital's Top Picks for 2021
RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

02/22/21 MKM Partners
Revolve Group price target raised to $42 from $24 at MKM Partners
02/22/21 Roth Capital
Revolve Group price target raised to $41 from $27 at Roth Capital
02/16/21 Piper Sandler
Revolve Group price target raised to $41 from $30 at Piper Sandler
12/30/20 Guggenheim
Revolve Group price target raised to $35 from $28 at Guggenheim
OPRX OptimizeRx
$57.73 /

+2.23 (+4.02%)

01/26/21 Lake Street
OptimizeRx price target raised to $54 from $40 at Lake Street
01/07/21 Lake Street
OptimizeRx price target raised to $40 from $26 at Lake Street
01/07/21 Roth Capital
OptimizeRx price target raised to $70 from $40 at Roth Capital
01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
CPE Callon Petroleum
$26.18 /

+1.71 (+6.99%)

01/21/21 Citi
Callon Petroleum price target raised to $16 from $6 at Citi
12/31/20 Truist
Callon Petroleum price target raised to $14 from $6 at Truist
12/17/20 RBC Capital
Callon Petroleum price target raised to $20 from $16 at RBC Capital
11/04/20 MKM Partners
Callon Petroleum price target raised to $15 from $10 at MKM Partners
MAXR Maxar Technologies
$45.52 /

-0.09 (-0.20%)

02/19/21 Canaccord
Maxar Technologies price target raised to $50 from $40 at Canaccord
01/21/21
Fly Intel: Top five analyst downgrades
01/21/21 JPMorgan
JPMorgan downgrades Maxar, says take profits after 85% rally
01/21/21 JPMorgan
Maxar Technologies downgraded to Neutral from Overweight at JPMorgan
CDNA CareDx
$79.23 /

+2.13 (+2.76%)

01/12/21 Piper Sandler
CareDx price target raised to $93 from $62 at Piper Sandler
01/04/21 Craig-Hallum
CareDx price target raised to $94 from $66 at Craig-Hallum
12/17/20 BTIG
CareDx price target raised to $80 from $55 at BTIG
12/10/20 Raymond James
CareDx price target raised to $75 from $62 at Raymond James
PSTG Pure Storage
$25.78 /

+0.21 (+0.82%)

02/22/21 Deutsche Bank
Pure Storage price target raised to $24 from $18 at Deutsche Bank
02/22/21 JMP Securities
Pure Storage price target raised to $35 from $26 at JMP Securities
02/18/21 JPMorgan
Pure Storage price target raised to $32 from $22 at JPMorgan
02/11/21 Wells Fargo
Pure Storage price target raised to $33 from $22 at Wells Fargo
NTNX Nutanix
$32.81 /

+0.77 (+2.40%)

01/13/21 William Blair
VMware downgraded to Market Perform at William Blair after executive exits
12/14/20 Oppenheimer
Nutanix upgraded to Outperform at Oppenheimer
12/14/20 Oppenheimer
Nutanix upgraded to Outperform from Perform at Oppenheimer
12/09/20 William Blair
New Nutanix CEO a 'best-of-both-worlds pick,' says William Blair
LB L Brands
$51.65 /

+0.525 (+1.03%)

02/18/21 UBS
L Brands price target raised to $54 from $46 at UBS
02/16/21 Jefferies
L Brands assumed with a Hold at Jefferies
02/08/21 Barclays
L Brands price target raised to $50 from $47 at Barclays
02/05/21 B. Riley Securities
L Brands price target raised to $58 from $55 at B. Riley Securities
WOW WideOpenWest
$13.03 /

+0.01 (+0.08%)

11/10/20 B. Riley Securities
WideOpenWest price target raised to $9 from $8 at B. Riley Securities
09/01/20 KeyBanc
TPG could use stake in WideOpenWest to monetize Astound, says KeyBanc
08/04/20 B. Riley Securities
B. Riley FBR upgrades 'extremely compelling' WideOpenWest to Buy
08/04/20 B. Riley Securities
WideOpenWest upgraded to Buy from Neutral at B. Riley FBR
MRNA Moderna
$144.71 /

-5.315 (-3.54%)

02/18/21 Jefferies
Moderna price target raised to $180 from $150 at Jefferies
02/18/21 Morgan Stanley
Moderna price target raised to $215 from $150 at Morgan Stanley
02/17/21 Piper Sandler
Moderna price target raised to $208 from $170 at Piper Sandler
02/03/21 Piper Sandler
Moderna's vaccine approved in Singapore, says Piper Sandler
PING Ping Identity
$32.52 /

+1.17 (+3.73%)

02/23/21 Deutsche Bank
Ping Identity initiated with a Hold at Deutsche Bank
02/01/21 Stephens
Ping Identity initiated with an Overweight at Stephens
01/21/21 Barclays
Ping Identity price target raised to $35 from $31 at Barclays
01/12/21 Mizuho
Ping Identity price target raised to $32 from $29 at Mizuho
WHD Cactus
$33.92 /

+3.335 (+10.90%)

01/11/21 Wolfe Research
Cactus downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
National Oilwell, Cactus upgraded as BofA positions for 'one last cycle'
01/06/21 BofA
Cactus upgraded to Buy from Neutral at BofA
12/21/20 Goldman Sachs
Cactus initiated with a Neutral at Goldman Sachs
PGNY Progyny
$53.33 /

+2.09 (+4.08%)

08/24/20 JPMorgan
Progyny price target raised to $35 from $30 at JPMorgan
08/06/20 SVB Leerink
Progyny price target raised to $44 from $35 at SVB Leerink
08/06/20 Citi
Progyny price target raised to $32 from $28 at Citi
07/01/20 SVB Leerink
SVB Leerink bullish on Progyny, initiates with an Outperform
NTAP NetApp
$71.48 /

+2.16 (+3.12%)

02/24/21 JPMorgan
NetApp price target raised to $63 from $58 at JPMorgan
02/22/21 Deutsche Bank
NetApp price target raised to $64 from $54 at Deutsche Bank
02/19/21 Longbow
NetApp upgraded to Buy from Neutral at Longbow
01/14/21 Barclays
NetApp price target raised to $67 from $54 at Barclays
KRA Kraton
$44.65 /

+1.44 (+3.33%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/16/20 Loop Capital
Kraton price target raised to $45 from $29 at Loop Capital
10/09/20 Truist
Kraton price target raised to $30 from $25 at Truist
10/06/20 Truist
Kraton price target raised to $25 from $20 at Truist
ZVO Zovio
$6.14 /

+0.68 (+12.45%)

01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
08/03/20 Barrington
Zovio price target raised to $10 from $8 at Barrington
07/08/20 Barrington
Zovio may have 'good case' for resumption of enrollment growth, says Barrington
RDFN Redfin
$91.61 /

+0.95 (+1.05%)

02/23/21 Truist
Redfin price target raised to $102 from $84 at Truist
02/19/21 Piper Sandler
Redfin purchase of RentPath 'strategically compelling,' says Piper Sandler
02/05/21 Goldman Sachs
Redfin upgraded to Neutral from Sell at Goldman Sachs
01/20/21 DA Davidson
Redfin downgraded to Neutral from Buy at DA Davidson
GPRE Green Plains
$26.02 /

+0.83 (+3.29%)

02/24/21
Green Plains files to sell $150M in stock, $150M in convertible senior notes
02/11/21 Roth Capital
Green Plains price target raised to $43 from $20 at Roth Capital
02/11/21 BMO Capital
Green Plains price target raised to $29 from $17 at BMO Capital
02/11/21 Jefferies
Jefferies says Green Plains investments may be worth $130/share if company right
TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

01/26/21 BTIG
Teladoc price target raised to $330 from $260 at BTIG
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/15/21 Benchmark
SOC Telemed initiated with a Buy at Benchmark
01/12/21 BTIG
Teladoc price target raised to $260 from $240 at BTIG
AMED Amedisys
$281.78 /

+1.51 (+0.54%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
GBT Global Blood Therapeutics
$49.20 /

+1.19 (+2.48%)

01/27/21 Oppenheimer
Global Blood Therapeutics' MAA accepted ahead of schedule, says Oppenheimer
01/20/21 Piper Sandler
Global Blood downgraded to Neutral from Overweight at Piper Sandler
12/15/20 H.C. Wainwright
Global Blood Therapeutics assumed with a Buy at H.C. Wainwright
12/03/20
Fly Intel: Top five analyst initiations
GH Guardant Health
$162.41 /

+2.14 (+1.34%)

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
01/14/21 Canaccord
Natera price target raised to $125 from $112 at Canaccord
01/12/21 Canaccord
Guardant Health price target raised to $170 from $145 at Canaccord
01/11/21
Fly Intel: Top five analyst initiations
ACA Arcosa
$68.21 /

+2.98 (+4.57%)

02/22/21 Sidoti
Arcosa downgraded to Neutral from Buy at Sidoti
12/16/20 Oppenheimer
Arcosa price target raised to $60 from $52 at Oppenheimer
12/15/20 CJS Securities
Arcosa downgraded to Market Perform from Outperform at CJS Securities
11/19/20
Fly Intel: Top five analyst downgrades
IIPR Innovative Industrial Properties
$220.34 /

+11.345 (+5.43%)

01/29/21 JMP Securities
Innovative Industrial Properties price target raised to $225 from $185 at JMP
01/07/21 BTIG
Innovative Industrial Properties price target raised to $218 from $177 at BTIG
12/23/20 Ladenburg
Innovative Industrial Properties downgraded to Neutral from Buy at Ladenburg
12/23/20 Piper Sandler
Innovative Industrial price target raised to $250 from $160 at Piper Sandler
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

02/02/21
Fly Intel: Top five analyst initiations
02/02/21 Piper Sandler
Nevro initiated with an Overweight at Piper Sandler
01/19/21 SVB Leerink
Nevro price target raised to $210 from $190 at SVB Leerink
01/19/21 Canaccord
Nevro price target raised to $203 from $167 at Canaccord
ESTC Elastic
$157.48 /

+4.36 (+2.85%)

02/19/21 RBC Capital
Elastic price target raised to $175 from $155 at RBC Capital
01/21/21 Goldman Sachs
Elastic initiated with a Neutral at Goldman Sachs
01/19/21 Truist
Elastic initiated with a Buy at Truist
01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
PNTG The Pennant Group
$57.96 /

+1.69 (+3.00%)

01/05/21 Truist
The Pennant Group price target raised to $60 from $44 at Truist
11/12/20 RBC Capital
The Pennant Group price target raised to $44 from $40 at RBC Capital
08/13/20 Truist
The Pennant Group price target raised to $40 from $25 at Truist
08/13/20 Stephens
The Pennant Group price target raised to $44 from $30 at Stephens
SPTN SpartanNash
$18.10 /

+0.055 (+0.30%)

01/07/21 Barclays
SpartanNash downgraded to Underweight from Equal Weight at Barclays
11/20/20 Jefferies
SpartanNash assumed with a Hold at Jefferies
10/10/20 BTIG
SpartanNash economics of Amazon pact uncertain, says BTIG
10/09/20 BMO Capital
SpartanNash's potential expansion with Amazon 'positive,' says BMO Capital
NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

02/22/21 BMO Capital
Nvidia price target raised to $680 from $650 at BMO Capital
02/22/21 Deutsche Bank
Nvidia price target raised to $550 from $515 at Deutsche Bank
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

02/22/21 Barclays
TechnipFMC downgraded to Equal Weight from Overweight at Barclays
02/18/21
Fly Intel: Top five analyst downgrades
02/18/21 Kepler Cheuvreux
TechnipFMC downgraded to Hold from Buy at Kepler Cheuvreux
02/18/21 UBS
TechnipFMC cut to Neutral at UBS on 'fair' valuation
HCC Warrior Met Coal
$25.60 /

+0.175 (+0.69%)

01/13/21 Deutsche Bank
Warrior Met Coal downgraded to Hold from Buy at Deutsche Bank
01/13/21 Deutsche Bank
Warrior Met Coal downgraded to Hold from Buy at Deutsche Bank
12/17/20 BMO Capital
Warrior Met Coal downgraded to Market Perform from Outperform at BMO Capital
12/07/20 Citi
Warrior Met Coal downgraded to Neutral from Buy at Citi
ZVO Zovio
$6.14 /

+0.68 (+12.45%)

WOW WideOpenWest
$13.03 /

+0.01 (+0.08%)

WHD Cactus
$33.92 /

+3.335 (+10.90%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

SPTN SpartanNash
$18.10 /

+0.055 (+0.30%)

RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RCII Rent-A-Center
$54.52 /

+0.27 (+0.50%)

PSTG Pure Storage
$25.78 /

+0.21 (+0.82%)

PNTG The Pennant Group
$57.96 /

+1.69 (+3.00%)

PING Ping Identity
$32.52 /

+1.17 (+3.73%)

PGNY Progyny
$53.33 /

+2.09 (+4.08%)

OPRX OptimizeRx
$57.73 /

+2.23 (+4.02%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NTNX Nutanix
$32.81 /

+0.77 (+2.40%)

NTAP NetApp
$71.48 /

+2.16 (+3.12%)

MRNA Moderna
$144.71 /

-5.315 (-3.54%)

MAXR Maxar Technologies
$45.52 /

-0.09 (-0.20%)

LB L Brands
$51.65 /

+0.525 (+1.03%)

KRA Kraton
$44.65 /

+1.44 (+3.33%)

IIPR Innovative Industrial Properties
$220.34 /

+11.345 (+5.43%)

HCC Warrior Met Coal
$25.60 /

+0.175 (+0.69%)

GPRE Green Plains
$26.02 /

+0.83 (+3.29%)

GH Guardant Health
$162.41 /

+2.14 (+1.34%)

GBT Global Blood Therapeutics
$49.20 /

+1.19 (+2.48%)

FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

CPE Callon Petroleum
$26.18 /

+1.71 (+6.99%)

CDNA CareDx
$79.23 /

+2.13 (+2.76%)

CCRN Cross Country Healthcare
$10.05 /

+0.51 (+5.35%)

AMED Amedisys
$281.78 /

+1.51 (+0.54%)

ACA Arcosa
$68.21 /

+2.98 (+4.57%)

  • 25
    Feb
  • 09
    Feb
  • 21
    Jan
  • 15
    Dec
  • 18
    Nov
  • 13
    Oct
  • 07
    Oct
  • 11
    Sep
  • 09
    Jul
  • 30
    Jun
  • 11
    Jun
  • 02
    Jun
  • 27
    May
  • 19
    May
  • 14
    May
  • 02
    Apr
TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

RCII Rent-A-Center
$54.52 /

+0.27 (+0.50%)

OPRX OptimizeRx
$57.73 /

+2.23 (+4.02%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

MRNA Moderna
$144.71 /

-5.315 (-3.54%)

LB L Brands
$51.65 /

+0.525 (+1.03%)

FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

SPTN SpartanNash
$18.10 /

+0.055 (+0.30%)

RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RCII Rent-A-Center
$54.52 /

+0.27 (+0.50%)

PSTG Pure Storage
$25.78 /

+0.21 (+0.82%)

PING Ping Identity
$32.52 /

+1.17 (+3.73%)

OPRX OptimizeRx
$57.73 /

+2.23 (+4.02%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NTNX Nutanix
$32.81 /

+0.77 (+2.40%)

NTAP NetApp
$71.48 /

+2.16 (+3.12%)

MRNA Moderna
$144.71 /

-5.315 (-3.54%)

LB L Brands
$51.65 /

+0.525 (+1.03%)

KRA Kraton
$44.65 /

+1.44 (+3.33%)

IIPR Innovative Industrial Properties
$220.34 /

+11.345 (+5.43%)

GH Guardant Health
$162.41 /

+2.14 (+1.34%)

GBT Global Blood Therapeutics
$49.20 /

+1.19 (+2.48%)

FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

CPE Callon Petroleum
$26.18 /

+1.71 (+6.99%)

CDNA CareDx
$79.23 /

+2.13 (+2.76%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

RVLV Revolve Group
$36.73 /

-0.36 (-0.97%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

PSTG Pure Storage
$25.78 /

+0.21 (+0.82%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NTNX Nutanix
$32.81 /

+0.77 (+2.40%)

NTAP NetApp
$71.48 /

+2.16 (+3.12%)

MRNA Moderna
$144.71 /

-5.315 (-3.54%)

MAXR Maxar Technologies
$45.52 /

-0.09 (-0.20%)

LB L Brands
$51.65 /

+0.525 (+1.03%)

FTI TechnipFMC
$7.60 /

+0.46 (+6.44%)

CPE Callon Petroleum
$26.18 /

+1.71 (+6.99%)

Earnings
Nevro sees FY21 revenue $430M-$450M, consensus $451.19M » 16:14
02/24/21
02/24
16:14
02/24/21
16:14
NVRO

Nevro

$171.76 /

+4.915 (+2.95%)

Revenue view assumes FDA…

Revenue view assumes FDA approval of PDN at the beginning of Q3 and a mid-single digit million revenue contribution from PDN in 2021, with the majority generated in Q4. For FY21, gross margin is expected to be approximately 69%, and operating expenses are expected to be approximately $370M, including litigation expenses and approximately $22 million of investment in a PDN launch and market development. Expects FY21 non-GAAP adjusted EBITDA of $0M-$15M, which compares to a non-GAAP adjusted EBITDA loss of $3.9M in 2020.

ShowHide Related Items >><<
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

NVRO Nevro
$171.76 /

+4.915 (+2.95%)

02/02/21
Fly Intel: Top five analyst initiations
02/02/21 Piper Sandler
Nevro initiated with an Overweight at Piper Sandler
01/19/21 SVB Leerink
Nevro price target raised to $210 from $190 at SVB Leerink
01/19/21 Canaccord
Nevro price target raised to $203 from $167 at Canaccord
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

  • 02
    Apr
NVRO Nevro
$171.76 /

+4.915 (+2.95%)

Earnings
Nevro sees Q1 revenue $84M-$86M, consensus $94.23M » 16:13
02/24/21
02/24
16:13
02/24/21
16:13
NVRO

Nevro

$171.79 /

+4.945 (+2.96%)

Expects Q1 operating…

Expects Q1 operating expenses $83M-$86M, including litigation expenses and additional investment in PDN market development.

ShowHide Related Items >><<
NVRO Nevro
$171.79 /

+4.945 (+2.96%)

NVRO Nevro
$171.79 /

+4.945 (+2.96%)

02/02/21
Fly Intel: Top five analyst initiations
02/02/21 Piper Sandler
Nevro initiated with an Overweight at Piper Sandler
01/19/21 SVB Leerink
Nevro price target raised to $210 from $190 at SVB Leerink
01/19/21 Canaccord
Nevro price target raised to $203 from $167 at Canaccord
NVRO Nevro
$171.79 /

+4.945 (+2.96%)

  • 02
    Apr
NVRO Nevro
$171.79 /

+4.945 (+2.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.